Tag archive for ‘GlenRock Israel’
Gali Weinreb On Monday, June 9th, 2014

VBL Therapeutics files for $75 million Nasdaq IPO

– VBL is developing drugs for the treatment of cancer and inflammatory diseases. On Friday,  VBL Therapeutics Ltd. (formerly Vascular Biogenics) published a draft prospectus with the US Securities More...

Enzymotec Seeks $100 Million Nasdaq Exit

– Enzymotec Ltd. Files Registration Statement for Proposed Secondary Offering – –  Enzymotec Ltd. (Nasdaq:ENZY) today announced that it has filed a registration statement on Form F-1 with More...

Roy Goldenberg On Wednesday, October 23rd, 2013

Content Recommendation Outbrain Raises $35 Million

– Outbrain had been reportedly planning a Wall Street IPO to raise $100-200 million at a company valuation of $700-800 million. – Outbrain co-founders Yaron Galai and Ori Lahav – Despite reports More...

- On Sunday, September 29th, 2013

Enzymotec raises $63.5 million in Nasdaq IPO

– The lipid-based products developer held the IPO at $14 per share, below its target of $16-18, but the share price rose 30% on Friday. – – Enzymotec Ltd. (Nasdaq: ENZY) has raised a net More...

Globes On Monday, September 9th, 2013

Israeli Outbrain seeks Wall Street IPO at $700-800 million valuation

– Like other Israeli start-ups, the content recommendations company is planning an IPO in 2014. –                                                                 More...

Globes On Sunday, August 25th, 2013

Enzymotec publishes Nasdaq IPO prospectus

– Enzymotec, which has developed a proprietary method for processing fatty acids, is seeking to raise $75 million. – – / By Gali Weinreb /  Nutritional supplements company Enzymotec More...

Wordpress site Developed by Fixing WordPress Problems